From: Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
HEC
(n = 96)
non-HEC
(n = 31)
p-value
Standard doses
(n = 98)
low dose
(n = 29)
Improvement, n (%)
83 (86%)
22 (71%)
0.048
80 (82%)
35 (86%)
0.568
Complete remission, n (%)
36 (38%)
6 (19%)
0.062
27 (28%)
15 (52%)
0.015